# María Reig

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maria-reig/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,379 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 60 |
| i10-index | 138 |
| Last Known Institution | Hospital Clínic de Barcelona |
| OpenAlex ID | https://openalex.org/A5080639399 |
| ORCID iD | https://orcid.org/0000-0002-5711-9534 |
| Works | 337 |

## Researcher papers

- [EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma](https://scholariq.org/papers/easl-clinical-practice-guidelines-on-the-management-of-hepatocellular-carcinoma/)
- [Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma](https://scholariq.org/papers/four-year-overall-survival-update-from-the-phase-iii-himalaya-study-of/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Hospital Clínic de Barcelona](https://scholariq.org/institutions/hospital-clinic-de-barcelona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.